skip to main content
Idioma:
Refinado por: assunto: Hcv remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Sofosbuvir and ledipasvir improve patient-reported outcomes in patients co-infected with hepatitis C and human immunodeficiency virus
Sofosbuvir and ledipasvir improve patient-reported outcomes in patients co-infected with hepatitis C and human immunodeficiency virus
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sofosbuvir and ledipasvir improve patient-reported outcomes in patients co-infected with hepatitis C and human immunodeficiency virus

Younossi, Z. M. ; Stepanova, M. ; Sulkowski, M. ; Naggie, S. ; Henry, L. ; Hunt, S.

Journal of viral hepatitis, 2016-11, Vol.23 (11), p.857-865 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
2
Clinical evaluation of sofosbuvir/ledipasvir in patients with chronic hepatitis C genotype 1 with and without prior daclatasvir/asunaprevir therapy
Clinical evaluation of sofosbuvir/ledipasvir in patients with chronic hepatitis C genotype 1 with and without prior daclatasvir/asunaprevir therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical evaluation of sofosbuvir/ledipasvir in patients with chronic hepatitis C genotype 1 with and without prior daclatasvir/asunaprevir therapy

Iio, Etsuko ; Shimada, Noritomo ; Takaguchi, Koichi ; Senoh, Tomonori ; Eguchi, Yuichiro ; Atsukawa, Masanori ; Tsubota, Akihito ; Abe, Hiroshi ; Kato, Keizo ; Kusakabe, Atsunori ; Miyaki, Tomokatsu ; Matsuura, Kentaro ; Matsunami, Kayoko ; Shinkai, Noboru ; Fujiwara, Kei ; Nojiri, Shunsuke ; Tanaka, Yasuhito

Hepatology research, 2017-11, Vol.47 (12), p.1308-1316 [Periódico revisado por pares]

Netherlands: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
3
The impact of ledipasvir/sofosbuvir on patient-reported outcomes in cirrhotic patients with chronic hepatitis C: the SIRIUS study
The impact of ledipasvir/sofosbuvir on patient-reported outcomes in cirrhotic patients with chronic hepatitis C: the SIRIUS study
Material Type:
Artigo 		Adicionar ao Meu Espaço

The impact of ledipasvir/sofosbuvir on patient-reported outcomes in cirrhotic patients with chronic hepatitis C: the SIRIUS study

Younossi, Zobair M. ; Stepanova, Maria ; Pol, Stanislas ; Bronowicki, Jean-Pierre ; Carrieri, Maria Patrizia ; Bourlière, Marc

Liver international, 2016-01, Vol.36 (1), p.42-48 [Periódico revisado por pares]

United States: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
4
Efficacy and Safety of Ledipasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C in Persons With Sickle Cell Disease
Efficacy and Safety of Ledipasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C in Persons With Sickle Cell Disease
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and Safety of Ledipasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C in Persons With Sickle Cell Disease

Moon, Juhi ; Hyland, Robert H. ; Zhang, Fangqiu ; Brainard, Diana M. ; Lanzkron, Sophie ; McHutchison, John G. ; Sulkowski, Mark

Clinical infectious diseases, 2017-09, Vol.65 (5), p.864-866 [Periódico revisado por pares]

United States: Oxford University Press

Texto completo disponível

Citações Citado por
5
Effectiveness of ledipasvir/sofosbuvir in real-world patients with chronic hepatitis C: a collaborative treatment approach
Effectiveness of ledipasvir/sofosbuvir in real-world patients with chronic hepatitis C: a collaborative treatment approach
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effectiveness of ledipasvir/sofosbuvir in real-world patients with chronic hepatitis C: a collaborative treatment approach

Johnson, Steven W ; Ammirati, Shelby R ; Hartis, Charles E ; Weber, Stephen F ; Morgan, Michael R ; Darnell, Timothy A ; Silwal, Adwait ; Schmidlin, Holly N ; Priest, David H

International journal of antimicrobial agents, 2017-06, Vol.49 (6), p.778-781 [Periódico revisado por pares]

Netherlands: Elsevier B.V

Texto completo disponível

Citações Citado por
6
The Discovery of Ledipasvir (GS-5885): The Potent Once-Daily Oral HCV NS5A Inhibitor in the Single-Tablet Regimen Harvoni
The Discovery of Ledipasvir (GS-5885): The Potent Once-Daily Oral HCV NS5A Inhibitor in the Single-Tablet Regimen Harvoni
Material Type:
Capítulo de Livro 		Adicionar ao Meu Espaço

The Discovery of Ledipasvir (GS-5885): The Potent Once-Daily Oral HCV NS5A Inhibitor in the Single-Tablet Regimen Harvoni

Link, John O. Sofia, Michael J.

HCV: The Journey from Discovery to a Cure, p.57-80

Cham: Springer International Publishing

Sem texto completo

Citações Citado por
7
8.23 - Harvoni: A Combination Therapy for Curing HCV
8.23 - Harvoni: A Combination Therapy for Curing HCV
Material Type:
Capítulo de Livro 		Adicionar ao Meu Espaço

8.23 - Harvoni: A Combination Therapy for Curing HCV

Sofia, M.J. ; Link, J.O.

Comprehensive Medicinal Chemistry III, 2017, p.558-582

Elsevier Ltd

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (6)
  2. Revistas revisadas por pares (5)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (5)
  2. Book Chapters  (2)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.